[ORGANIZATION]
Wedbush
Featured in 17 tracked stories · first seen
Situations
AI infrastructure demand drives tech sector growth and risk
31 clusters · 133 sources · last updated
Latest: TSMC reports October revenue surge amid 3D DRAM manufacturing rumors
The expansion of AI infrastructure continues to drive record growth across the technology and semiconductor sectors. TSMC reported record Q3 2026 revenue of approximately $46.72 billion, a 50.9% increase from the previou
Semiconductor industry market and technology trends
12 clusters · 93 sources · last updated
Latest: TSMC denies reports of 3D DRAM production plans
The semiconductor industry continues to show signs of recovery, driven by intense demand for artificial intelligence infrastructure. ASML has raised its financial outlook, noting that demand for its equipment is so high
Micron AI memory boom and leadership restructuring
99 clusters · 379 sources · last updated
Latest: Micron stock declines following Intel memory cost warnings
In May 2026, Micron began producing 1-alpha DDR4-compatible DRAM at a new Virginia fab, supported by a $2 billion expansion funded partly by the CHIPS Act. Throughout June, the company reported record earnings driven by
Netflix business model transition and financial volatility
18 clusters · 100 sources · last updated
Latest: Netflix faces declining user engagement and stock value
Netflix is undergoing a business transition, pivoting from a pure subscription model toward new monetization strategies such as an ad-supported tier and paid sharing plans. Following a decision in early 2025 to stop repo
Global pursuit of sovereign AI and infrastructure
76 clusters · 473 sources · last updated
Latest: German companies express high security concerns over AI agents
Global efforts to establish technological sovereignty through artificial intelligence (AI) are accelerating, characterized by massive infrastructure investments and evolving regulatory frameworks. In Europe, the implemen
Also covered in
-
Disc Medicine faces stock downgrade and FDA regulatory requirements
[BUSINESS] · 2 sources ·
-
Cullinan Therapeutics receives price target increase to $42.00
[BUSINESS] · 3 sources ·
-
Cogent Biosciences receives moderate buy rating from analysts
[BUSINESS] · 2 sources ·
-
US Fintech Companies Paymentus and Paycom Experience Stock Movements and Analyst Updates
[BUSINESS] · 2 sources ·